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Abstract
 
Since transglutaminases create covalent 
 
g
 
-glutamyl-
 
e
 
-lysine
cross-links between extracellular matrix proteins they are
prime candidates for stabilizing tissue during wound heal-
ing. Therefore, we studied the temporo-spatial expression of
transglutaminase activity in skin regenerating from cul-
tured epithelial autografts in severely burned children by
the specific incorporation of monodansylcadaverine into
cryostat sections from skin biopsies obtained between 5 d to
17 mo after grafting. The dansyl label was subsequently im-
munolocalized in the epidermis, dermal connective tissue,
and along the basement membrane. Incubation of cryosec-
tions of normal and regenerating skin with purified tissue
transglutaminase confirmed the dermo–epidermal junction
and the papillary dermis as targets for this enzyme and re-
vealed that in regenerating skin transamidation of the base-
ment membrane zone was completed only 4–5 mo after
grafting. Immunoelectron microscopy revealed that three
distinct regions on the central portion of anchoring fibrils
were positive for monodansylcadaverine in normal skin
which were negative during the initial phase of de novo for-
mation of anchoring fibrils in regenerating skin. Biochemi-
cally, we identified collagen VII as potential substrate for
tissue transglutaminase. Thus, tissue transglutaminase ap-
pears to play an important role not only in cross-linking of
the papillary dermis but also of the dermo–epidermal junc-
tion in particular. (
 
J. Clin. Invest.
 
 1996. 98:1174–1184.) Key
words: wound healing 
 
•
 
 transglutaminase 
 
•
 
 burns 
 
•
 
 skin 
 
•
 
collagen VII
 
Introduction
 
It is a common observation that cultured keratinocyte autografts
(cultured epithelial autografts [CEA],
 
1
 
 see reference 1) are frag-
ile and sensitive to mechanical shearing forces for at least 2 mo
post grafting (pg) (Gobet, R., S. Altermatt, C. Meuli-Simmen, M.
Raghunath, M. Benathan, A. Dietl, and M. Meuli, manuscript
submitted for publication). During this critical period, separation
of the newly formed epidermis from the neodermis can occur ei-
ther spontaneously or by mechanical friction. This points to a
transitory instability of the dermo–epidermal junction (DEJ) ei-
ther by absence of supramolecular structures or their cross-link-
ing, or both. The integrity of the DEJ is largely guaranteed by an-
choring fibrils, which is illustrated by the fact that mutations and
functional deficits of their major component, collagen VII (2),
cause a blistering skin disease collectively known as dystrophic
epidermolysis bullosa (for review see reference 3). Transglutami-
nase-derived cross-links were demonstrated recently by immu-
nohistochemistry along the basement membrane (4). In fact, sev-
eral basement membrane constituents (BM-40/osteonectin/
SPARC and nidogen/entactin) are good substrates for tissue
transglutaminase (4–7). These findings suggest that transglutami-
nase cross-linking contributes to the stability of the DEJ and,
consequently, may play a role in wound healing processes in skin
and in particular in the integration of CEA. Since CEA are in-
creasingly used to cover burn wounds (8) and other large skin de-
fects, understanding the mechanisms underlying tissue integra-
tion is therefore of great clinical importance.
Transglutaminases form a family of proteins with at least
six different gene products in higher vertebrates that have
specialized in the cross-linking of protein assemblies in differ-
ent physiological situations (9). Transglutaminases (E.C.
2.3.2.13) catalyze a Ca
 
2
 
1
 
-dependent transfer reaction between
the 
 
g
 
-carboxamide group of a peptide-bound glutamine resi-
due and various primary amines (9–11). Most commonly, 
 
g
 
-glu-
tamyl-
 
e
 
-lysine cross-links are formed in or between proteins
by reaction with the 
 
e
 
-amino group of lysine residues. The
role of keratinocyte and epidermal transglutaminase in cross-
linking proteins forming the cornified cell envelope in termi-
nal differentiation of keratinocytes is well established (12–14).
In fact, a congenital keratinization disorder, autosomal reces-
sive lamellar ichthyosis, has been linked recently to mutations
in the gene coding for keratinocyte transglutaminase (15, 16).
Less understood is the function of tissue transglutaminase
which is expressed widely in vertebrate tissues (5, 17, 18) and
is also synthesized by dermal fibroblasts
 
2
 
 (19) and basal kera-
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tinocytes (12, 20). Tissue transglutaminase has been implicated
in processes as different as GTP-binding in receptor signaling
(21) and intracellular cross-linking during programmed cell
death (22), but there is increasing evidence for a primary role
for tissue transglutaminase in stabilizing extracellular protein
assemblies such as collagen fibrils (4, 23), microfibrils,
 
2,3
 
 the
pericellular fibronectin matrix (24), and basement membranes
(18). In an attempt to understand the role of tissue trans-
 
3. Glanville, R.W., and R.Q. Quian, manuscript submitted for publi-
cation.
Figure 1. Visualization of transglutaminase activity in normal and regenerating skin after keratinocyte autografting. Transglutaminase activity 
was detected in skin cryostat sections by incubation with the transglutaminase amine donor MDC in the presence of Ca21. Incorporation of 
MDC was visualized using an antidansyl antiserum and fluorescein-conjugated secondary antibodies. (a) Normal skin (NS): MDC is incorpo-
rated into the basement membrane and fibrillar connective tissue structures of the dermis. This pattern is consistent with tissue type transgluta-
minase activity. In contrast, epidermal and keratinocyte transglutaminase activity is visualized in the intercellular space of keratinocytes of the 
granular and cornified layer. (b) Competition of MDC with putrescine (MDC 1 Pu) prevents dermal and epidermal MDC incorporation to a 
large extent. (c) In the presence of exogenous tissue transglutaminase (MDC 1TGII) MDC incorporation is largely restricted to the DEJ and 
dermal connective tissue, preferentially the papillary tips, indicating that substrate sites for this enzyme are limited and primarily present in the 
dermal compartment. (d) 7 d pg: while MDC incorporation is prominent in the suprabasal layers of the epidermis and in the deeper zone of the 
dermis, it is barely visible at the DEJ and the fibroblast-rich infiltrate of the neodermis. (f) MDC incorporation in the presence of exogenous tis-
sue transglutaminase reveals an intensely labeled reticular pattern of connective tissue structures that contain abundant substrate sites which 
have not been transamidated yet. Tissue transglutaminase shows a clear preference for connective tissue structures in the neodermis including 
the basement membrane. Epidermal transglutaminase activity appeared elevated in the autografts throughout the regeneration process as indi-
cated by the incomplete competitive inhibition of this enzyme by putrescine (b and e; see also Fig. 2). Bar, 10 mm.
 
glutaminase in the de novo formation of the DEJ, we moni-
tored transglutaminase activity during skin regeneration after
transplantation of CEA and demonstrated that anchoring
fibrils are stabilized by transglutaminase cross-links.
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Methods
 
Patients.
 
A 5-yr-old girl (R.R.) and a 6-yr-old boy (S.K.) received
CEA as primary treatment for burns (full thickness burns of 65 and
62% of the total body surface area). A 14-yr-old boy (D.G.) received
CEA for post-burn scar revision. In R.R. and S.K., CEA were grafted
onto subcutaneous fat after necrosectomy. In D.G., CEA were
grafted onto a thin layer of dermal remnants after deep dermabrasion
of scarred and hyperpigmented areas in the face and removal of hy-
pertrophic scars at the neck. Scalp biopsies were taken under local
anesthesia and CEA sheets were prepared by a commercial labora-
tory (Biosurface Technology Inc., Boston, MA). For histological fol-
Figure 2. Visualization of trans-
glutaminase activity in advanced 
keratinocyte autografts. Trans-
glutaminase activity was de-
tected on cryostat sections as 
outlined in Fig. 1. (a) 2 mo pg: 
MDC incorporation at the DEJ 
and upper neodermis is still 
faint. (b) Incubation with MDC 
in the presence of exogenous 
transglutaminase (MDC 1 
TGII) demonstrates the neoder-
mis as an as yet incompletely 
transamidated target. (c) 4 mo 
pg: the DEJ expresses full trans-
glutaminase activity. The neo-
dermis shows endogenous trans-
glutaminase activity 
preferentially associated with 
capillaries and single cells.
(d) Application of tissue trans-
glutaminase highlights potential 
substrate sites in the neodermal 
connective tissue. (e) 17 mo pg: 
MDC incorporation does not 
differ from that observed with 
normal skin. (f) Incubation with 
MDC and purified tissue trans-
glutaminase does not change the 
staining pattern any more, indi-
cating saturation of potential 
cross-linking sites. Bar, 10 mm.
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Figure 3. Immunofluorescence localization of Factor XIIIa in normal and regenerating skin after keratinocyte autografting. Factor XIIIa was de-
tected on cryostat sections with antibodies directed to its a-subunit. (A) Normal skin: pericellularly labeled dendritic cells in the papillary dermis 
are lined up along the DEJ. In addition, Factor XIII–positive cells are associated with papillary capillaries. (B) 7 d pg: granular staining of sprout-
ing capillaries. (C) 6 wk pg: blood vessels and a few pericapillary dendrocytes are positive. (D) 10 wk pg: patches of Factor XIII–positive cells are 
evident in the papillary neodermis. (E) 4 mo pg: blood vessels are strongly positive and the number of dendritic cells has increased. (F) 17 mo pg: 
numerous Factor XIII–positive cells are present in the papillary neodermis with a distribution comparable with normal skin. Bar, 10 mm.
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low-up, 4-mm punch biopsies were taken during general or local an-
esthesia, with informed consent of the patients/parents. The biopsies
were taken from the left submandibular angle (D.G.), the ventral left
thigh (S.K.), and the ventral right thigh (R.R.). Additionally, time-
matched biopsies from meshed split thickness skin grafts were avail-
able in R.R. (dorsal right thigh). Biopsy time points covered days 5–9,
13–14, 21–28, 62–72, and 120–140. In addition, a 17-mo biopsy (
 
5
 
 510
d) was available in D.G. A time point 0 biopsy was taken in all three
children from the wound bed immediately before CEA transplanta-
tion. The immunohistological findings were compared with those
from normal skin of R.R. and S.K. (normal skin of D.G. was not
available), as well as to those obtained with nonwounded skin from
eight adult volunteers.
 
Electron microscopy.
 
Biopsies obtained from R.R. were split,
and one-half was used for cryosectioning (see below) the other half
was immersed in 4% glutaraldehyde in 0.1 M sodium-cacodylate for
24–48 h at 7
 
8
 
C. Specimens were osmicated, dehydrated, and embed-
ded in EPON 812. Ultrathin sections were viewed with a Philips EM
401 electron microscope at 60 kV (Philips, Enschede, The Netherlands).
 
Immunohistochemical detection of transglutaminase activity in
skin sections.
 
5-
 
m
 
m cryostat sections from skin biopsies of eight
healthy adult volunteers and from CEA were preincubated with 1%
BSA in 0.1 M Tris/HCl, pH 8.2, for 30 min at room temperature
(RT). Transglutaminase activity was detected by subsequent incuba-
tion in Tris buffer containing 12 
 
m
 
M monodansylcadaverine (MDC)
and 5 mM CaCl
 
2
 
 (18). Control sections were incubated with MDC
and 2 mM putrescine or MDC and 10 mM EDTA instead of CaCl
 
2
 
.
Parallel sections were incubated in the same buffer containing guinea
pig liver transglutaminase (15 
 
m
 
g/ml) which had been purified as de-
scribed (25). Both endogenous and exogenous enzyme reactions were
allowed to proceed for 1 h at RT and then stopped by washing the
slides for 5 min in PBS/10 mM EDTA and two further washes in plain
PBS. Incorporated dansyl label was finally detected by incubation for
1 h at RT with polyclonal antidansyl serum (5). After three washes in
PBS, bound antibody was detected with FITC-coupled swine anti–
rabbit IgG (Dako, Hamburg, Germany) diluted 1:30 in PBS for 30
min. Preparations were mounted in Mowiol (Hoechst) prepared in
Tris/HCl, pH 8.6. Factor XIII was visualized using an affinity-purified
rabbit antibody against the a-subunit (26) diluted 1:100 overnight.
The secondary antibody was used as described. Photographs were
taken on an HP5 plus film (Ilford Ltd., Basildon, United Kingdom) or
Tmax 3200 (Eastman Kodak Co., Rochester, NY) using Polyvar (Reich-
ert-Jung, Heidelberg, Germany) or Axiophot (Zeiss, Jena, Germany)
epifluorescence equipment, respectively. For preembedding immu-
noelectron microscopy, incorporated MDC was detected with pri-
mary antibodies as described above and visualized by incubation with
Figure 4. Ultrastructural localization of transglutaminase cross-linking sites on anchoring fibrils in normal skin. Skin cryostat sections were incu-
bated with MDC for 1 h as in Fig. 1. MDC covalently incorporated into extracellular matrix structures was visualized by indirect immunoperoxi-
dase staining. All electron micrographs show the papillary dermis and the DEJ as characterized by hemidesmosomes (hd) of the basal kerati-
nocytes of the epidermis and the lamina densa (ld) of the basement membrane. (A–E) ultrathin sections were counterstained with lead citrate 
only. (A–D) Transglutaminase cross-linking sites are visualized as three major bands (dashes) on individual anchoring fibrils. (E) Inhibition of 
the transglutaminase by EDTA prevents cross-linking of MDC to anchoring fibrils (arrowheads). (F–I) Additional light counterstain with uranyl 
acetate enhances contrast and highlights the striation pattern on anchoring fibrils obtained with the antidansyl antibodies. (I) Inhibition of trans-
glutaminase with EDTA abolishes dansyl immunostaining on anchoring fibrils. Bars, 100 nm.
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a peroxidase-conjugated goat anti–rabbit secondary antibody (Jack-
son Laboratories, Bar Harbor, ME) 1:100 in PBS for 30 min at RT.
After fixation in 2.5.% glutaraldehyde for 30 min at RT, the peroxi-
dase reaction was developed with 0.1% diaminobenzidine tetrahy-
drochloride (Fluka, Buchs, Switzerland) in 0.1 M Tris/5% sucrose,
pH 7.5, in the presence of 0.03% hydrogen peroxide (27). Sections
were processed for electron microscopy as described except that ul-
trathin sections were counterstained with lead citrate only.
 
Identification of collagen VII as a substrate for purified tissue
transglutaminase.
 
The triple helical domain of human collagen VII
was isolated by limited pepsin digestion of human placental tissue ex-
tracts as described previously (28) and 0.5-ml aliquots were precipi-
tated with ethanol and the pellets were dissolved in 0.1 M Tris/0.4 M
NaCl, pH 8.3, and incubated overnight at 37
 
8
 
C with 250 
 
m
 
Ci of
[
 
3
 
H]putrescine (Du Pont/New England Nuclear, Boston, MA) and
8 
 
m
 
g of purified tissue transglutaminase and 5 mM CaCl
 
2 
 
in the pres-
ence or absence of 20 mM EDTA. A recombinant NC-2 fragment
representing the carboxy terminus of procollagen VII was expressed
as a bacterial fusion protein as described elsewhere (29). Approxi-
mately 10 
 
m
 
g of the recombinant protein was dissolved in 0.1 M Tris/
0.4 M NaCl, pH 8.3, and incubated for 17 h as described in the pres-
ence or absence of EDTA. In parallel, 20 
 
m
 
g of purified fibronectin
(Sigma Immunochemicals, St. Louis, MO) was used as a positive con-
trol. Incubation was terminated by precipitation of proteins with
methanol/chloroform (30). Pellets were resuspended in SDS-PAGE
sample buffer and proteins were separated by SDS-PAGE under re-
ducing conditions in a 4.5–15% polyacrylamide gel and transferred
onto nitrocellulose. Immunoblotting was carried out with affinity-
purified domain-specific collagen VII antibodies as described (28,
29). After development of the blot, each lane was cut into 2-mm slices
which were presolved in 100 
 
m
 
l of dimethylformamide in liquid scin-
tillation vials. Finally, 2 ml of scintillant (Lumasafe Plus, Lumac,
Groningen, The Netherlands) was added and radioactivity was deter-
mined.
 
Results
 
Transglutaminase activity in normal human skin.
 
To detect en-
dogenous transglutaminase activity, cryostat sections of human
Figure 5. Development of anchoring fibrils in keratinocyte autografts. (a) 1 mo pg: the lamina densa (ld) is continuous; thin anchoring fibrils (af) 
(arrowheads) are visible opposite to hemidesmosomes (hd). The collagen fibers of the papillary dermis are loosely packed. Bundles of 10–12-nm 
microfibrils (mf) are present. (b) 2 mo pg: more and thicker anchoring fibrils are detectable. (c) 4 mo pg: anchoring fibrils are abundant, have 
gained thickness, and display cross-striation. Also, anchoring plaques (ap) are detectable. (d) Normal skin obtained from a meshed split skin 
graft of the same patient (R.R.) shows normal distribution and size of anchoring fibrils. Ultrathin sections were fully counterstained with uranyl 
acetate and lead citrate. Bar, 100 nm.
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skin were incubated with MDC, a potent amine donor sub-
strate for transglutaminase, and covalently attached dansyl
epitopes (through enzymatic activity) were subsequently visu-
alized with specific antibodies. It has been shown that the pat-
tern of MDC incorporation on tissue sections correlates well
with the distribution of active transglutaminase in situ (5, 18).
In normal human skin (Fig. 1 
 
a
 
), MDC incorporation was de-
tected along the DEJ which is known to contain transglutami-
nase cross-links (4, 18) and in differentiating epidermis
(presumably representing keratinocyte and epidermal trans-
glutaminase activity) (12, 13). MDC incorporation was also ob-
served in the microfibrillar apparatus of the papillary dermis
and surrounding papillary capillaries, which is in concert with
earlier observations that tissue transglutaminase is expressed
by dermal fibroblasts
 
2
 
 (19) and vascular endothelia (31). Incu-
bation with MDC in the presence of an 80-fold excess of pu-
trescine, a competitive substrate to MDC, prevented incorpo-
ration of MDC to a large extent (Fig. 1 
 
b
 
), whereas sections
incubated with MDC in the presence of EDTA (transglutami-
nases are calcium dependent) showed no incorporation of
MDC (results not shown). Supplementing the reaction mixture
with purified tissue transglutaminase led to preferential incor-
poration of MDC into the DEJ and connective tissue of the
papillary dermis (Fig. 1 
 
c
 
). This localized the preferential tar-
get proteins for tissue transglutaminase in skin.
 
Transglutaminase activity in regenerating skin after trans-
plantation of CEA.
 
Transglutaminase activity was detected as
described for normal skin on cryosections from skin biopsies
obtained at different time points (7 d, and 2, 4, and 17 mo) af-
ter grafting. The pattern of proteins cross-linked by endoge-
nous transglutaminase in the dermis was markedly altered
(Fig. 1 
 
d
 
 and Fig. 2) and did not appear normal until 17 mo pg
(Fig. 2 
 
e
 
). The amount of MDC cross-linked to structures in
the DEJ was low during the first 2 mo pg (Fig. 1 
 
d
 
 and Fig. 2).
Extensive cross-linking at the DEJ was appreciable after 4 mo
(Fig. 2 
 
c
 
) and the pattern appeared normal after 17 mo pg
(Fig. 2 
 
e
 
) when compared with normal skin (Fig. 1 
 
a
 
). The
neodermis was dominated during the first 4 wk by a fibro-
blast-rich infiltrate which expressed transglutaminase activity
(Fig. 1 
 
d
 
). The pattern of MDC incorporation was initially
dominated by cell-bound transglutaminase activity in the cell-
rich infiltrate, but became gradually substituted by a more
Figure 6. Immunoelectron microscopic localization of transglutaminase cross-links on anchoring fibrils of regenerating and meshed split normal 
skin from the same patient. Transglutaminase activity was visualized as described in Fig. 4. Ultrathin sections were counterstained with lead cit-
rate only. (a) 1 mo pg: transamidation of anchoring fibrils is not detectable, although first thin anchoring fibrils are present at this stage. (b) 2 mo 
pg: the MDC incorporation is detectable on anchoring fibrils. (c) 4 mo pg, anchoring fibrils display a three-band pattern at the central portion, 
also the lateral aspect of collagen fibrils is decorated with MDC-positive patches. (d) Normal skin from a meshed split skin graft: thick anchoring 
fibrils are present which show a two- or three-band pattern of transamidation. (e–h) Control experiments (corresponding to a–d, respectively): 
incubation of the cryostat section with MDC in the presence of EDTA causes complete absence of dansyl-positive structures. Bar, 100 nm.
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web-like pattern characteristic of fibrillar structures in the ex-
tracellular compartment (Fig. 2 e). In the presence of purified
tissue transglutaminase, MDC was extensively cross-linked to
a network of fibrils in the neodermis 7 d pg and later (Fig. 1 f
and Fig. 2, b and d), which was not evident after visualization
of endogenous transglutaminase activity. This shows that nu-
merous target sites for cross-linking by transglutaminase are
available in the newly deposited matrix, indicating that cross-
linking of ECM structures is a slow process and primarily not
limited by the amount of ECM proteins available. Normal lev-
els of cross-linking were reached 17 mo pg since the MDC in-
corporation pattern resembled the pattern in normal skin.
Furthermore, inclusion of exogenous tissue transglutaminase
in the reaction did not change the pattern significantly, indi-
cating saturation of cross-linking sites in the matrix (Fig. 2 f).
To assess the contribution of the plasma transglutaminase
Factor XIIIa (FXIII) to the dansyl incorporation, we directly
immunolocalized the a-subunit of FXIII in normal and regen-
erating skin (Fig. 3). As described recently (32), FXIII was as-
sociated in normal skin mostly with dendritic cells and blood
vessels in the dermis. In regenerating skin, FXIII1 blood ves-
sels were seen early after grafting (Fig. 3 B), whereas FXIII1
dendritic cells appeared sparsely in the papillary neodermis
during the first 2 mo pg (Fig. 3, C and D). Expression of FXIII
on blood vessels was comparable with normal 4 mo pg (Fig. 3
E) but the overall population density of FXIII1 cells includ-
ing dendritic cells reached a distribution similar to normal
skin only after 17 mo (Fig. 3 F). Neither normal nor regener-
ating skin showed Factor XIIIa associated with connective tis-
sue elements including the DEJ, except for the excision mar-
gins of the biopsies where some bleeding had occurred.
Transglutaminase-mediated cross-links are present on an-
choring fibrils of the DEJ of normal skin. To analyze the tar-
gets for the cross-linking at the DEJ, incorporated MDC was
detected on skin sections with specific antibodies and peroxi-
dase-conjugated secondary antibodies and then visualized by
electron microscopy. MDC incorporation was detected as
three horizontal bands on the central portions of anchoring
fibrils indicating transglutaminase cross-linking at these sites
(Fig. 4). MDC was also detected on microfibrils and fibrillar
collagens as reported in a previous study2 (data not shown).
Transglutaminase cross-linking of de novo forming anchor-
ing fibrils in keratinocyte autografts follows their assembly with
a time lag. Thin anchoring fibrils were regularly observed in
regenerating skin 1 mo pg (Fig. 5 a) and appeared to increase
in number and thickness after 2 mo pg (Fig. 5 b). The develop-
ment of anchoring fibrils with a cross-striated central portion
and the appearance of anchoring plaques took 4 mo (Fig. 5 c).
In comparison to normal skin from the same patient (Fig. 5 d),
the anchoring fibrils still appeared thinner, and possibly more
numerous. When the incorporation of MDC was studied by
immunoelectron microscopy, no label could be identified on
anchoring fibrils 1 mo pg (Fig. 6, a and e) although these struc-
tures were morphologically apparent. Anchoring fibrils be-
came positive for MDC incorporation 2 mo pg (Fig. 6, b and f)
and the staining pattern did not change significantly thereafter
Figure 7. Transamidation of collagen VII by tissue transglutaminase. The triple helical domain (A) and the NC-2 domain (B) of human collagen 
VII were incubated with purified tissue transglutaminase and the amine donor [3H]putrescine in the presence (closed symbols) or absence (open 
symbols) of EDTA. Proteins were separated by SDS-PAGE with a 4–15% polyacrylamide gel, transferred onto nitrocellulose, and detected with 
specific antibodies (on duplicate lanes). Immunoblot strips were cut in slices and analyzed for 3H-label to compare distribution of the radioactiv-
ity with the migration of immunologically identified proteins. Migration of molecular mass standards is indicated on the bottom of each panel. 
(A) The triple helical domain is a poor amine acceptor substrate in comparison to the enzyme which shows extensive autotransamidation. (B) 
The recombinant NC-2 domain is an excellent amine acceptor substrate and competes efficiently with the autotransamidation of the enzyme. 
The radioactivity seen between 20 and 25 kD probably reflects incorporation of [3H]putrescine into small bacterial proteins contaminating the 
recombinant NC-2 domain preparation. CVII, triple helical domain of collagen VII; NC-2, carboxy-terminal, noncollagenous domain of collagen 
VII; TG II, tissue transglutaminase.
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except for increased thickness of anchoring fibrils after 4 mo
(Fig. 6, c and g). The pattern of the cross-linking in three hori-
zontal bands was comparable with that of normal anchoring
fibrils (Fig. 6, d and h) and seemingly occurred at all three sites
at the same time.
Collagen VII acts as an amine acceptor in tissue transglutamin-
ase-catalyzed cross-linking. To obtain further information on
the cross-linking of anchoring fibrils by tissue transglutami-
nase, we investigated whether different domains of collagen
VII serve as amine acceptor substrates for tissue transglutami-
nase in vitro. Therefore, the triple helical domain of collagen
VII, isolated from human placenta by limited pepsin digest,
and the recombinant carboxy-terminal NC-2 domain were in-
cubated with tissue transglutaminase and [3H]putrescine in the
presence of calcium. This resulted in modest incorporation of
the amine donor substrate into the collagenous collagen VII
domain and strong autocatalytic labeling of the enzyme (Fig. 7
A). In contrast, the recombinant NC-2 domain proved to be an
excellent amine acceptor substrate effectively competing with
autotransamidation of the enzyme (Fig. 7 B). No incorpora-
tion of [3H]putrescine was obtained when transglutaminase ac-
tivity was inhibited by EDTA (Fig. 7 A). Preliminary data with
a recombinant NC-2 domain expressed in eukaryotic cells con-
firmed these findings (data not shown).
Discussion
This study provides evidence that skin regenerating from kera-
tinocyte autografts is substantially cross-linked by trans-
glutaminase in a time-dependent fashion. However, this pro-
cess takes z 1.5 yr for the dermis and z 4 mo for the DEJ to
reach a degree which is comparable with normal skin. Re-
markably, the time lag of transglutaminase cross-linking of the
DEJ coincides with our experience that the attachment of ke-
ratinocyte autografts is particularly unstable for the first 2 mo
pg (Gobet, R., S. Altermatt, C. Meuli-Simmen, M. Raghunath,
M. Benathan, A. Dietl, and M. Meuli, manuscript submitted
for publication). This is clinically evident by the formation of
mechanically induced blisters which can result in substantial
loss of transplanted material. Furthermore, subclinical blister-
ing can be found during histological examinations of these
grafts,3 a common feature also seen in heritable skin disorders
with a defective DEJ (3). However, blistering ceases after this
critical period and does not reoccur at any later time point.3
We found that transglutaminase activity along the DEJ is re-
markably low during this critical period, indicating that trans-
glutaminase cross-linking might be a crucial factor for the sta-
bility of the DEJ. In fact, the ultrastructural analysis of normal
skin revealed transamidation of anchoring fibrils, the struc-
tures crucial for dermo–epidermal cohesion (2). However, in
keratinocyte autografts we did not observe cross-linking of
MDC to anchoring fibrils before 2 mo pg, although anchoring
fibrils were consistently found in ultrastructural studies al-
ready 1 mo pg. Interestingly, the appearance of transglutamin-
ase cross-links on anchoring fibrils coincided with the clinical
stabilization of the grafts.
Three distinct regions on the central portion of anchoring
fibrils were identified as targets for transglutaminase cross-
linking. This central portion is known to contain the triple helical
domains and the carboxy-terminal telopeptides of antiparal-
lely aligned collagen VII molecules (2). This region also con-
tains a part of the carboxy-terminal noncollagenous NC-2 do-
main that is retained after removal of a carboxy-terminal
propeptide from the procollagen VII molecule (29). As de-
picted in Fig. 8, dimer formation leads to an antiparallel over-
lap of the carboxy termini of collagen VII molecules. Our bio-
chemical data suggest that the triple helical region of collagen
VII is a weak and the NC-2 domain a very attractive glutami-
nyl substrate for tissue transglutaminase. In fact, the NC-2 do-
main contains four glutamine residues proximal to the putative
cleavage site (29), whereas the histidine tag of the recombinant
fusion proteins contains none. The distinct pattern of trans-
glutaminase cross-linking sites on anchoring fibrils raises the
question of the partners involved in this process. Potentially,
collagen VII as the major if not the sole structural component
of anchoring fibrils (2) would be able to form homopolymers
stabilized by intermolecular g-glutamyl-e-lysine cross-links. It
is conceivable that in the antiparallel overlap model of two col-
lagen VII molecules the trimmed NC-2 domain as amine ac-
Figure 8. Schematic representation of the current model for the as-
sembly of procollagen VII resulting in the formation of anchoring 
fibrils. Procollagen VII molecules align in an antiparallel fashion and 
propeptides from either NC-2 domain are removed. The amino acid 
sequence of one remaining NC-2 domain (shaded area) is given on 
the left in single letter code. Glutamine residues as potential donor 
substrates for transglutaminase cross-linking are highlighted (bold-
face). The different regions of the molecule are not drawn to scale, 
the overlap region is hypothetical.
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ceptor substrate would face an amine donor. It remains to be
shown whether the triple helical domain, a poor amine accep-
tor substrate, might be a good amine donor substrate. In fact,
there would be several lysyl residues available in the carboxy-
terminal triple helical region and the NC-2 domain itself. It
should also be noted that the triple helical domain of collagen
VII contains a fibronectin binding site (33). Fibronectin in turn
is an excellent substrate for tissue transglutaminase (34–37)
and might become cross-linked to anchoring fibrils, as may
other hitherto unidentified proteins.
The occurrence of transglutaminase cross-linking sites only
on anchoring fibrils with a certain degree of maturity could
also be a reflection of the regulation of transglutaminase activ-
ity in regenerating skin. In fact, a potential regulation of the
cross-linking by limited secretion of transglutaminases has
been suggested by several studies (for review see reference 9).
It has been demonstrated that overexpression of tissue trans-
glutaminase does not necessarily lead to increased cross-link
formation (38, 39). This suggests that transglutaminases are
present in an inactive form in an intracellular pool from which
they are slowly released (40). Our observation of mainly cell-
associated transglutaminase activity during the first 4 mo of re-
generation in the papillary dermis might therefore point toward
the same direction. Our attempts to directly immunolocalize
tissue transglutaminase with antibodies raised against the
guinea pig enzyme failed because of their very limited cross-reac-
tivity with the human enzyme. Since dermal fibroblasts2 (19)
and basal keratinocytes (12, 20) both have been shown to ex-
press tissue transglutaminase, it appears likely that this en-
zyme is acting on the DEJ. However, we cannot completely
exclude that a part of the cell-associated transglutaminase ac-
tivity might be attributable to FXIII1 cells. However, FXIII1
perivascular dendritic cells that were mostly located in the re-
ticular dermis during the first 4 mo showed a normal distribu-
tion pattern in the papillary dermis only 17 mo pg. These re-
sults are in agreement with previous findings for postburn
dermis (31). In contrast, transglutaminase (keratinocyte and
epidermal transglutaminase) activity in the neoepidermis was
high at all stages of skin regeneration and the pattern consis-
tent with the formation of cornified cell envelopes.
Human skin represents a complex system of extracellular
matrix proteins serving different biological tasks. Two differ-
ent transglutaminases have been found to play a role in the
terminal differentiation of epidermal keratinocytes in order to
form a protective barrier represented by the stratum corneum
(for reviews see references 9, 12, 13). Tissue transglutaminase
is operative at the DEJ (4, 18) and underlying dermal struc-
tures, particularly the microfibrillar apparatus.2 This highlights
a functional partnership between molecules designed to con-
vey integrity and shape to a particular tissue and members of
the transglutaminase family which are highly efficient biologi-
cal glues (9, 41, 42). In fact, many studies support this function
of transglutaminases in wound healing situations. It has been
reported that the topical treatment of incisional skin wounds
with putrescine, resulting in competitive inhibition of trans-
glutaminase cross-linking, causes decreased wound breaking
strength (43). Furthermore, the systemic administration of
MDC or spermidine, also competitive inhibitors of trans-
glutaminase cross-linking, decreases healing of gastric and
duodenal stress ulcers (44). Hence, it is tempting to speculate
that the external application of purified or recombinant tissue
transglutaminase might accelerate the formation of a stable
DEJ and underlying dermis not only in keratinocyte autografts
but also in other wound healing situations. The use of tissue
transglutaminase in the experimental repair of the rat optic
nerve (45) or articular cartilage (Juergensen, K., D. Aeschli-
mann, V. Cavin, M. Genge, and E.B. Hunziker, manuscript
submitted for publication) has been reported. Therefore, tis-
sue transglutaminase seems to be a promising representative
of an ancient biological principle in the quest for a therapeutic
cross-linker of extracellular matrix proteins.
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